NPI: 1053382655 · FOLEY, AL 36535 · Ambulatory Surgical Clinic/Center · NPI assigned 01/31/2006
Authorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
| Authorized Official | LALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL) |
| NPI Enumeration Date | 01/31/2006 |
Other providers sharing the same authorized official: LALOR, PAULA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 17,135 | $306K |
| 2019 | 17,980 | $424K |
| 2020 | 19,173 | $481K |
| 2021 | 24,617 | $677K |
| 2022 | 28,314 | $890K |
| 2023 | 29,431 | $1.06M |
| 2024 | 16,981 | $638K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 29,091 | 25,236 | $1.30M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 18,811 | 15,877 | $1.29M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 9,938 | 9,199 | $435K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 10,896 | 10,049 | $269K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 880 | 719 | $175K |
| 80053 | Comprehensive metabolic panel | 14,579 | 11,953 | $141K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 8,032 | 7,382 | $128K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 16,451 | 13,381 | $122K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 5,477 | 5,242 | $93K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1,965 | 1,773 | $91K |
| 70450 | Computed tomography, head or brain; without contrast material | 703 | 620 | $58K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1,349 | 1,178 | $53K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1,085 | 693 | $47K |
| 71045 | Radiologic examination, chest; single view | 4,423 | 3,786 | $36K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2,467 | 1,961 | $31K |
| 71046 | Radiologic examination, chest; 2 views | 1,933 | 1,714 | $29K |
| 81001 | 7,823 | 6,217 | $26K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 179 | 160 | $26K |
| 84703 | 3,118 | 2,686 | $18K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 600 | 443 | $13K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1,037 | 154 | $11K |
| 87807 | 752 | 703 | $11K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 699 | 628 | $8K |
| 83690 | 1,007 | 880 | $7K | |
| 84484 | 899 | 606 | $6K | |
| 82553 | 559 | 411 | $5K | |
| 82550 | 953 | 667 | $5K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 12 | 12 | $5K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,048 | 521 | $5K |
| 81003 | 1,424 | 1,301 | $4K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 37 | 24 | $4K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 41 | 38 | $4K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 347 | 274 | $4K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 69 | 59 | $3K |
| 83735 | 345 | 287 | $2K | |
| 83704 | 95 | 51 | $2K | |
| 85610 | 391 | 326 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | 128 | 75 | $1K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 18 | 17 | $1K |
| 82172 | 95 | 51 | $1K | |
| 80061 | Lipid panel | 109 | 64 | $1K |
| 85027 | 224 | 180 | $1K | |
| 85007 | 211 | 168 | $862.65 | |
| 72125 | Computed tomography, cervical spine; without contrast material | 14 | 12 | $673.44 |
| 83695 | 95 | 51 | $671.60 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 744 | 632 | $631.85 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1,276 | 1,054 | $571.93 |
| 82247 | 190 | 155 | $541.30 | |
| 85730 | 192 | 163 | $369.05 | |
| 85651 | 133 | 77 | $365.40 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 57 | 52 | $205.69 |
| 73630 | 13 | 12 | $200.10 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 73 | 53 | $170.61 |
| 83036 | Hemoglobin; glycosylated (A1C) | 13 | 12 | $169.68 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 13 | 12 | $161.76 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 12 | 12 | $131.37 |
| J7030 | Infusion, normal saline solution , 1000 cc | 60 | 44 | $95.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 36 | 30 | $66.77 |
| J1170 | Injection, hydromorphone, up to 4 mg | 19 | 13 | $52.16 |
| 86900 | 16 | 12 | $29.61 | |
| 86901 | 16 | 12 | $29.34 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 42 | 38 | $27.72 |
| 86140 | 12 | 12 | $24.42 | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 67 | 49 | $10.59 |
| 87077 | 38 | 25 | $0.00 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 147 | 85 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 39 | 38 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 14 | 14 | $0.00 |